Antihypertensive effect of MCHF in L-NAME induced hypertensive rats

Tipsuchon  Aiamsa-ard; Thidarat  Phetmanee; Thitiya  Lukkunaprasit

Authors

Tipsuchon Aiamsa-ard Department of Pharmacology, Faculty of Pharmacy, Rangsit University, Patumthani 12000, Thailand
Thidarat Phetmanee Department of Pharmacology, Faculty of Pharmacy, Rangsit University, Patumthani 12000, Thailand
Thitiya Lukkunaprasit Department of Pharmacology, Faculty of Pharmacy, Rangsit University, Patumthani 12000, Thailand

Keywords:

antihypertensive, hepatotoxicity, lipid peroxidation, Moa Chub’s formulation, MCHF, L-NAME, nitric oxide

Abstract

Moa Chub’s formulation (MCHF), a traditional medicinal formulation, is used in Thailand for treatment of hypertension. It is composed of 7 kinds of medical herbs, Cyperusrotundus, Tinosporacrispa, Tinosporacordifolia, Acmellaoleracea, Syzygiumaromaticum, Piper chaba, and Zingiberofficinale. This study aimed to determine the effect of MCHF on blood pressure by investigating nitric oxide (NO) and lipid peroxidation in N-nitro-L-arginine methyl ester (L-NAME) induced hypertensive rats. Rats were gavaged with MCHF (100, 200 and 400 mg/kgBW/day) and fed with L-NAME in drinking water for 21 days. Non- invasive tail cuff was used to monitor blood pressure every 7 days. At the end of trial, blood sample was collected and plasma nitric oxide and lipid peroxidation were measured. In addition, the cytotoxicity of MCHF was evaluated in human hepatoma HepG2 cell line. Cell viability of HepG2 cells was measured by MTT assay. The results showed that administration of MCHF extract at dose of 200 and 400 mg/kgBW/day significantly decreased a rise of systolic blood pressure in hypertensive rats induced by L-NAME on the 21st day. Moreover, MCHF significantly increased the serum level of NO and reduced the level of MDA compared to the group that was treated with only L-NAME. The high doses of MCHF may lead to increased risk of hepatotoxicity. These results suggested that MCHF has the potential ability to be used as herbal remedy to treat hypertension. However, further studies are needed to explore the mechanism of antihypertensive effect of MCHF in detail.

References

Attia, D. M., Verhagen, A. M. G., Stroes, E. S., van Faassen, E. E., Gröne, H.-J., De Kimpe, S. J., & Joles, J. A. (2001). Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. Journal of the American Society of Nephrology, 12(12), 2585-2593.

Buege, J. A., & Aust, S. D. (1978). [30] Microsomal lipid peroxidation. Methods in enzymology, 52, 302-310.

Bunbupha, S., Pakdeechote, P., Kukongviriyapan, U., Prachaney, P., & Kukongviriyapan, V. (2014). Asiatic acid reduces blood pressure by enhancing nitric oxide bioavailability with modulation of eNOS and p47phox expression in l‐NAME‐induced hypertensive rats. Phytotherapy research, 28(10), 1506-1512.

Doggrell, S. A., & Brown, L. (1998). Rat models of hypertension, cardiac hypertrophy and failure. Cardiovascular research, 39(1), 89-105.

Donato, M. T., Jover, R., & Gomez-Lechon, M. J. (2013). Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. Current drug metabolism, 14(9), 946-968.

Duarte, J., Jiménez, R., O'valle, F., Galisteo, M., Pérez-Palencia, R., Vargas, F., & Tamargo, J. (2002). Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. Journal of hypertension, 20(9), 1843-1854.

Godsan, I., & Choosongsang, Y. (2012). Acute toxicity test of Thai formulated herbs for antihypertension. (A senior project for the degree of Bachelor of Science in Biomedical Sciences, Rangsit University, Thailand).

Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical biochemistry, 126(1), 131-138.

Grunfeld, S., Hamilton, C. A., Mesaros, S., McClain, S. W., Dominiczak, A. F., Bohr, D. F., & Malinski, T. (1995). Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension, 26(6), 854-857.

Jameson, M., Dai, F.-X., Lüscher, T., Skopec, J., Diederich, A., & Diederich, D. (1993). Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension, 21(3), 280-288.

Joffres, M., Falaschetti, E., Gillespie, C., Robitaille, C., Loustalot, F., Poulter, N., & Campbell, N. (2013). Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ open, 3(8), e003423.

Katsumi, H., Nishikawa, M., & Hashida, M. (2007). Development of nitric oxide donors for the treatment of cardiovascular diseases. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Cardiovascular & Hematological Agents), 5(3), 204-208.

Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005). Global burden of hypertension: analysis of worldwide data. The lancet, 365(9455), 217-223.

Khare, C. P. (2008). Indian medicinal plants: an illustrated dictionary: Springer Science & Business Media.

Khumkhrong, P., & Kunkaew, T. (2012). Subchronic toxicity tests of Thai formulated herbs for antihypertension in mice and rats. (A senior project for the degree of Bachelor of Science in Biomedical Sciences, Rangsit university, Thailand).

Kopkan, L., & Majid, D. S. (2005). Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension, 46(4), 1026-1031.

Kumar, K. V., & Das, U. (1993). Are free radicals involved in the pathobiology of human essential hypertension? Free radical research communications, 19(1), 59-66.

Lacy, F., O'connor, D. T., & Schmid-Schönbein, G. W. (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. Journal of hypertension, 16(3), 291-303.

Madeachumporn, N., Pothikanith, A., Panjanon, T. (2014). Cytotoxicity test of Moa Chub's herbal formulation on white blood cells by MTT assay. Paper presented at the 2nd Academic Science and Tecnology conference (ASTC), Bangkok Thailand, pp. 201-205.

Mori, Y., Ohyanagi, M., Koida, S., Ueda, A., Ishiko, K., & Iwasaki, T. (2006). Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats. Hypertension research, 29(3), 187-195.

Nair, A. B., & Jacob, S. (2016). A simple practice guide for dose conversion between animals and human. Journal of basic and clinical pharmacy, 7(2), 27-31. DOI: 10.4103/0976-0105.177703

Nakazono, K., Watanabe, N., Matsuno, K., Sasaki, J., Sato, T., & Inoue, M. (1991). Does superoxide underlie the pathogenesis of hypertension? Proceedings of the National Academy of Sciences, 88(22), 10045-10048.

Nakmareong, S., Kukongviriyapan, U., Pakdeechote, P., Kukongviriyapan, V., Kongyingyoes, B., Donpunha, W., . . . Phisalaphong, C. (2012). Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertension Research, 35(4), 418-425.

Ortiz, M. C., Manriquez, M. C., Romero, J. C., & Juncos, L. A. (2001). Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension, 38(3), 655-659.

Panza, J. A., Casino, P. R., Kilcoyne, C. M., & Quyyumi, A. A. (1993). Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation, 87(5), 1468-1474.

Ribeiro, M. O., Antunes, E., De Nucci, G., Lovisolo, S. M., & Zatz, R. (1992). Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension, 20(3), 298-303.

Shesely, E. G., Maeda, N., Kim, H.-S., Desai, K. M., Krege, J. H., Laubach, V. E., & Smithies, O. (1996). Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences, 93(23), 13176-13181.

Shin, J.-W., Seol, I.-C., & Son, C.-G. (2010). Interpretation of animal dose and human equivalent dose for drug development. The Journal of Korean Oriental Medicine, 31(3), 1-7.

Snopov, S., Teryukova, N., Sakhenberg, E., Teplyashina, V., & Nasyrova, R. (2017). Use of HepG2 cell line for evaluation of toxic and metabolic antipsychotic action. Cell and Tissue Biology, 11(5), 405-415.

Sun, J., Zhang, X., Broderick, M., & Fein, H. (2003). Measurement of Nitric Oxide Production in Biological Systems by Using Griess Reaction Assay. Sensors, 3(8), 276-284. https://doi.org/10.3390/s30800276

Suzuki, H., Swei, A., Zweifach, B. W., & Schmid-Schönbein, G. W. (1995). In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hypertension, 25(5), 1083-1089.

Takahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts 2nd, R. L., & Badr, K. F. (1992). Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. Journal of Clinical Investigation, 90(1), 136-141. DOI: 10.1172/JCI115826

Tse, W., Maxwell, S., Thomason, H., Blann, A., Thorpe, G., Waite, M., & Holder, R. (1994). Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. Journal of human hypertension, 8(11), 843-849.

Ülker, S., McKeown, P. P., & Bayraktutan, U. (2003). Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD (P) H oxidase activities. Hypertension, 41(3), 534-539.

Vaziri, N. D., Lin, C.-Y., Farmand, F., & Sindhu, R. K. (2003). Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension. Kidney international, 63(1), 186-194.

Yeon, J. H., Na, D., & Park, J. K. (2010). Hepatotoxicity assay using human hepatocytes trapped in microholes of a microfluidic device. Electrophoresis, 31(18), 3167-3174.